How do Metronidazole Drawbacks Impact Patient Compliance and Therapeutic Outcomes in Treating Amoebiasis in Rwanda

Journal Title: International Journal of TROPICAL DISEASE & Health - Year 2016, Vol 17, Issue 3

Abstract

Amoebiasis is a parasitic disease with significant public health concerns in the Tropics. Metronidazole which is the first line most common prescribed medicine has shown a number of side effects difficult to tolerate by some patients, and many cases of true or erroneous treatment failure or frequent relapses have been observed among students of the University of Rwanda. This study aimed to evaluate how metronidazole side effects impact patients’ compliance, misuse practice, and therapeutic outcomes. A cross-sectional survey was conducted using a self-administered questionnaire to 115 students who had used before or were on metronidazole treatment for amoebiasis at the time of study. The data showed almost all respondents experienced at least one of the known metronidazole side effects including nausea, vomiting, headache, dry mouth or metallic taste, stomach upset, loss of appetite, dizziness, fatigue, somnolence, constipation, diarrhoea, rash, dysuria, itching and fever. About 36.8% of respondents were judged noncompliant, stopping taking medicine. There was a significant association between the number of side effects experienced per respondent and the status of patient compliance; and also between compliance status and clinical improvement (p<0.001). Notwithstanding patient’s noncompliance and a possible actual metronidazole resistance, some of relapses could be due to incomplete prescribing regimen which does not associate lumen (anti cysts) molecules and metronidazole. Prescribers are invited to seriously address this issue for a better achievement of amoeba eradication.

Authors and Affiliations

Etienne Dusengeyezu, Justin Ntokamunda Kadima

Keywords

Related Articles

Descriptive Characterization of Epidemic Meningococcal Serogroup W in the Upper West Region of Ghana

Aims: In recent time, Nm W outbreaks have been on the increase in the African meningitis ‘belt’. One of such outbreaks occurred in the Upper West Region of Ghana from December, 2015 to April 2016. The epidemiological fea...

Properties and Drug-likeness of Compounds That Inhibit Ebola Virus Disease (EVD)

Aims: To present the molecular structures of compounds that has been shown to inhibit the proliferation of Ebola virus. To elucidate the molecular properties of these virus inhibiting compounds. Study Design: The molecu...

High Prevalence of Isolated Hepatitis B Core Antibody among Adults in Oyo State, Nigeria: The Need for Review of Diagnostic and Vaccination Guidelines

Background: Ten years of neonatal immunization with hepatitis B vaccine has not had any significant effect on the prevalence of the disease in Nigeria. Aim: To investigate hepatitis B virus (HBV) markers as potential ris...

The Study of Social Profile and Some Health Problems Associated With Body Weight Disorders in Upper Egypt Male Youth

Background: Body weight disorder is a common health problem, unfortunately. The excess weight of the enlarged adipose tissue mass together with the metabolic changes of obesity can induce serious health problems and incr...

Monitoring of Human Onchocerciasis in Delta State, Nigeria

Background: In Delta State, free doses of ivermectin are distributed annually to communities through the Community Directed Treatment with Ivermectin (CDTI). Despite this intervention approach, pockets of endemic foci st...

Download PDF file
  • EP ID EP329131
  • DOI 10.9734/IJTDH/2016/27075
  • Views 56
  • Downloads 0

How To Cite

Etienne Dusengeyezu, Justin Ntokamunda Kadima (2016). How do Metronidazole Drawbacks Impact Patient Compliance and Therapeutic Outcomes in Treating Amoebiasis in Rwanda. International Journal of TROPICAL DISEASE & Health, 17(3), 1-7. https://europub.co.uk/articles/-A-329131